Your browser doesn't support javascript.
loading
Guidelines for the purification and characterization of extracellular vesicles of parasites.
Fernandez-Becerra, Carmen; Xander, Patrícia; Alfandari, Daniel; Dong, George; Aparici-Herraiz, Iris; Rosenhek-Goldian, Irit; Shokouhy, Mehrdad; Gualdron-Lopez, Melisa; Lozano, Nicholy; Cortes-Serra, Nuria; Karam, Paula Abou; Meneghetti, Paula; Madeira, Rafael Pedro; Porat, Ziv; Soares, Rodrigo Pedro; Costa, Adriana Oliveira; Rafati, Sima; da Silva, Anabela-Cordeiro; Santarém, Nuno; Fernandez-Prada, Christopher; Ramirez, Marcel I; Bernal, Dolores; Marcilla, Antonio; Pereira-Chioccola, Vera Lucia; Alves, Lysangela Ronalte; Portillo, Hernando Del; Regev-Rudzki, Neta; de Almeida, Igor Correia; Schenkman, Sergio; Olivier, Martin; Torrecilhas, Ana Claudia.
Affiliation
  • Fernandez-Becerra C; ISGlobal, Barcelona Institute for Global Health Hospital Clínic-Universitat de Barcelona Barcelona Spain.
  • Xander P; IGTP Institut d'Investigació Germans Trias i Pujol Badalona (Barcelona) Spain.
  • Alfandari D; CIBERINFEC ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III Madrid Spain.
  • Dong G; Departamento de Ciências Farmacêuticas Laboratório de Imunologia Celular e Bioquímica de Fungos e Protozoários Departamento de Ciências Farmacêuticas Instituto de Ciências Ambientais Químicas e Farmacêuticas Universidade Federal de São Paulo (UNIFESP) São Paulo Brazil.
  • Aparici-Herraiz I; Department of Biomolecular Sciences Weizmann Institute of Science (WIS) Rehovot Israel.
  • Rosenhek-Goldian I; The Research Institute of the McGill University Health Centre McGill University Montréal Québec Canada.
  • Shokouhy M; ISGlobal, Barcelona Institute for Global Health Hospital Clínic-Universitat de Barcelona Barcelona Spain.
  • Gualdron-Lopez M; Department of Chemical Research Support WIS Rehovot Israel.
  • Lozano N; Department of Immunotherapy and Leishmania Vaccine Research Pasteur Institute of Iran Tehran Iran.
  • Cortes-Serra N; ISGlobal, Barcelona Institute for Global Health Hospital Clínic-Universitat de Barcelona Barcelona Spain.
  • Karam PA; Departamento de Ciências Farmacêuticas Laboratório de Imunologia Celular e Bioquímica de Fungos e Protozoários Departamento de Ciências Farmacêuticas Instituto de Ciências Ambientais Químicas e Farmacêuticas Universidade Federal de São Paulo (UNIFESP) São Paulo Brazil.
  • Meneghetti P; ISGlobal, Barcelona Institute for Global Health Hospital Clínic-Universitat de Barcelona Barcelona Spain.
  • Madeira RP; Department of Biomolecular Sciences Weizmann Institute of Science (WIS) Rehovot Israel.
  • Porat Z; Departamento de Ciências Farmacêuticas Laboratório de Imunologia Celular e Bioquímica de Fungos e Protozoários Departamento de Ciências Farmacêuticas Instituto de Ciências Ambientais Químicas e Farmacêuticas Universidade Federal de São Paulo (UNIFESP) São Paulo Brazil.
  • Soares RP; Departamento de Ciências Farmacêuticas Laboratório de Imunologia Celular e Bioquímica de Fungos e Protozoários Departamento de Ciências Farmacêuticas Instituto de Ciências Ambientais Químicas e Farmacêuticas Universidade Federal de São Paulo (UNIFESP) São Paulo Brazil.
  • Costa AO; Flow Cytometry Unit Life Sciences Core Facilities, WIS Rehovot Israel.
  • Rafati S; Instituto René Rachou/FIOCRUZ - MG Belo Horizonte Minas Gerais Brazil.
  • da Silva AC; Departamento de Análises Clínicas e Toxicológicas Faculdade de Farmácia, Universidade Federal de Minas Gerais (UFMG) Belo Horizonte Minas Gerais Brasil.
  • Santarém N; Department of Immunotherapy and Leishmania Vaccine Research Pasteur Institute of Iran Tehran Iran.
  • Fernandez-Prada C; Host-Parasite Interactions Group Institute of Research and Innovation in Health University of Porto Porto Portugal.
  • Ramirez MI; Department of Biological Sciences Faculty of Pharmacy University of Porto Porto Portugal.
  • Bernal D; Host-Parasite Interactions Group Institute of Research and Innovation in Health University of Porto Porto Portugal.
  • Marcilla A; Department of Biological Sciences Faculty of Pharmacy University of Porto Porto Portugal.
  • Pereira-Chioccola VL; Faculty of Veterinary Medicine Université de Montréal Québec Canada.
  • Alves LR; EVAHPI - Extracellular Vesicles and Host-Parasite Interactions Research Group Laboratório de Biologia Molecular e Sistemática de Tripanossomatideos Instituto Carlos Chagas-Fiocruz Curitiba Paraná Brasil.
  • Portillo HD; Departament de Bioquímica i Biologia Molecular, Facultat de Ciències Biològiques Universitat de València Burjassot Valencia Spain.
  • Regev-Rudzki N; Àrea de Parasitologia, Departament de Farmàcia i Tecnologia Farmacèutica i Parasitologia Universitat de València Burjassot Valencia Spain.
  • de Almeida IC; Laboratório de Biologia Molecular de Parasitas e Fungos, Centro de Parasitologia e Micologia Instituto Adolfo Lutz (IAL) São Paulo Brasil.
  • Schenkman S; Laboratório de Regulação da Expressão Gênica Instituto Carlos Chagas Fiocruz Paraná Curitiba Brazil.
  • Olivier M; Research Center in Infectious Diseases Division of Infectious Disease and Immunity CHU de Quebec Research Center Department of Microbiology Infectious Disease and Immunology Faculty of Medicine University Laval Quebec City Quebec Canada.
  • Torrecilhas AC; ISGlobal, Barcelona Institute for Global Health Hospital Clínic-Universitat de Barcelona Barcelona Spain.
J Extracell Biol ; 2(10): e117, 2023 Oct.
Article in En | MEDLINE | ID: mdl-38939734
ABSTRACT
Parasites are responsible for the most neglected tropical diseases, affecting over a billion people worldwide (WHO, 2015) and accounting for billions of cases a year and responsible for several millions of deaths. Research on extracellular vesicles (EVs) has increased in recent years and demonstrated that EVs shed by pathogenic parasites interact with host cells playing an important role in the parasite's survival, such as facilitation of infection, immunomodulation, parasite adaptation to the host environment and the transfer of drug resistance factors. Thus, EVs released by parasites mediate parasite-parasite and parasite-host intercellular communication. In addition, they are being explored as biomarkers of asymptomatic infections and disease prognosis after drug treatment. However, most current protocols used for the isolation, size determination, quantification and characterization of molecular cargo of EVs lack greater rigor, standardization, and adequate quality controls to certify the enrichment or purity of the ensuing bioproducts. We are now initiating major guidelines based on the evolution of collective knowledge in recent years. The main points covered in this position paper are methods for the isolation and molecular characterization of EVs obtained from parasite-infected cell cultures, experimental animals, and patients. The guideline also includes a discussion of suggested protocols and functional assays in host cells.
Key words